Figure 5

Human rIL-2 transiently increases proliferation of CD4⁺ T cell subset . Ki67 expression was measured intracellularly in CD4⁺ T cells (top panel). Ki67 expression was then assessed in each CD4⁺ T cell subset (N, CM, EM or TD) at days 0 and 7 after IL-2 treatment (bottom panel). IL-2-treated macaques were #056212, #056216 (low dose) and #056230, #056238 (high dose).